logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12036312 B1

PDFFull Text
Date of Patent:
Jul. 16, 2024

Filed:

Mar. 15, 2017

Non-aqueous topical compositions comprising a halogenated salicylanilide

Applicants:

Union Therapeutics A/s, Hellerup, DK;

University of Copenhagen, København K, DK;

Inventors:

Morten Otto Alexander Sommer, Hellerup, DK;

Ping Li, Dyssegård, DK;

Camilla Hasling Frandsen, Copenhagen N, DK;

Hanne Mørck Nielsen, Hillerød, DK;

Petra Alexandra Priemel, Dyssegård, DK;

Thomas Rades, Copenhagen, DK;

Assignees:

UNION THERAPEUTICS A/S, Hellerup, DK;

KØBENHAVNS UNIVERSITET (UNIVERSITY OF COPENHAGEN), Copenhagen, DK;

Attorney:

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.

Primary Examiner:

Layla Soroush

Int. Cl.
CPC ...
A61K 31/277 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 31/167 (2006.01); A61K 31/203 (2006.01); A61K 31/327 (2006.01); A61K 31/609 (2006.01); A61K 45/06 (2006.01); A61K 47/10 (2017.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61P 17/10 (2006.01); A61P 31/04 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0014 (2013.01); A61K 9/06 (2013.01); A61K 31/167 (2013.01); A61K 31/203 (2013.01); A61K 31/327 (2013.01); A61K 31/609 (2013.01); A61K 45/06 (2013.01); A61K 47/10 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01); A61P 17/10 (2018.01); A61P 31/04 (2018.01);
Abstract

The present invention relates to non-aqueous topical compositions comprising a halogenated salicylanilide and the use of such compositions in the topical treatment or prevention of diseases and infections, particularly conditions caused by Gram-positive bacteria, for example the topical treatment or prevention of skin infections such as acne, atopic dermatitis and impetigo. Also disclosed are methods for preparing the gel composition.

Find Patent Forward Citations

Loading…